iShares LifePath Target Date 2065 ETF (NYSEARCA:ITDI) Stock Price Down 0.5% – What’s Next?

iShares LifePath Target Date 2065 ETF (NYSEARCA:ITDIGet Free Report) traded down 0.5% during trading on Wednesday . The stock traded as low as $41.94 and last traded at $41.94. Approximately 3,069 shares changed hands during trading, a decline of 34% from the average session volume of 4,627 shares. The stock had previously closed at $42.17.

iShares LifePath Target Date 2065 ETF Stock Down 0.5%

The stock has a market cap of $26.00 million, a price-to-earnings ratio of 20.19 and a beta of 0.88. The stock’s 50 day moving average price is $41.41 and its two-hundred day moving average price is $39.44.

Institutional Investors Weigh In On iShares LifePath Target Date 2065 ETF

An institutional investor recently raised its stake in iShares LifePath Target Date 2065 ETF stock. Heck Capital Advisors LLC boosted its stake in shares of iShares LifePath Target Date 2065 ETF (NYSEARCA:ITDIFree Report) by 20.4% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 8,143 shares of the company’s stock after purchasing an additional 1,380 shares during the period. Heck Capital Advisors LLC owned approximately 1.77% of iShares LifePath Target Date 2065 ETF worth $306,000 at the end of the most recent quarter.

iShares LifePath Target Date 2065 ETF Company Profile

(Get Free Report)

The iShares LifePath Target Date 2065 ETF (ITDI) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches. The fund is intended for investors who anticipate retiring around 2065 ITDI was launched on Oct 17, 2023 and is issued by BlackRock.

Featured Stories

Receive News & Ratings for iShares LifePath Target Date 2065 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares LifePath Target Date 2065 ETF and related companies with MarketBeat.com's FREE daily email newsletter.